FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely an agent exhibiting antioxidant, photoprotective and geroprotective action, and may be used for development of pharmacological preparations neutralising an adverse health effect of UV light and visible ranges, and inactivating toxic action of the age pigment. The agent represents an interaction product of the equimolar amounts of 6-hydroxy-2-aminobenzothiazole and N-acetyl-L-cysteine on boiling in an ethanol solution.
EFFECT: invention provides high antioxidant activity and high stability under visible and UV light.
7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTANCE POSSESSING ANTIOXIDANT, GEROPROTECTING AND ANTI-ISCHEMIC ACTIVITY AND METHOD FOR ITS PREPARING | 2004 |
|
RU2276138C2 |
| 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SALT WITH CARNITINE HYDRATE, HAVING ANTIOXIDANT ACTIVITY, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2817094C1 |
| ANTIOXIDANT ANTI-INFLAMMATORY PREPARATION FOR ANIMALS | 2018 |
|
RU2686462C1 |
| USE OF THE COMPOUND OF FORMULA I, A PHARMACEUTICAL COMPOSITION, A MEDICINAL AGENT | 2016 |
|
RU2730854C2 |
| ANTIOXIDANT, ANTIHYPERGLYCEMIC, HYPOLIPIDEMIC AND ANTISHOCK N-ACETYLCYSTEINATE 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE | 2006 |
|
RU2357955C2 |
| MEDICATION FOR PREVENTION AND TREATMENT OF OPHTHALMOLOGICAL DISEASES | 2008 |
|
RU2359658C1 |
| MEDICINE USED FOR PREVENTION AND TREATMENT OF OPHTHALMOLOGIC DISEASES AND METHOD OF ITS PREPARATION | 2010 |
|
RU2442581C1 |
| DOSAGE FORM FOR INJECTION IN FORM OF SOLUTION AND STABILIZER FOR ITS PREPARATION | 2020 |
|
RU2755094C1 |
| SOLUTION WITH OF ENDOTHELIOPROTECTIVE POTENCY | 2017 |
|
RU2643605C1 |
| METHOD FOR PREPARING BIOLOGICALLY ACTIVE NANOLIQUID OF FERRIC OXIDE (II, III) NANOPARTICLES AND 3-HYDROXY PYRIDINE DERIVATIVE | 2012 |
|
RU2493857C1 |
